This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
07/30/15 - 12:11:36 PM ET (BATS BZX Real-time Price)
Div Yield: --
ZGNX Day's Range
ZGNX 52 Week Range
ZGNX Business Summary
Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders in the United States. Its marketed product includes Zohydro ER, an extended-release formulation of hydrocodone for the treatment of severe chronic pain.View ZGNX key stats
Zogenix, Inc. - ZGNX - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Zogenix, Inc. as a
Hold with a ratings score of C-.
Report Snippet: We rate ZOGENIX INC (ZGNX) a HOLD. The primary factors that have impacted our rating are mixed - some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its solid stock price performance, notable return on equity and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including poor profit margins and unimpressive growth in net income.